FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francine Foss

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Bertrand Coiffier; Francine M Foss; Matthew Greenwood; Barbara Balser; John Balser; Peter Borchmann; Dolores Caballero; Susan Carroll; Franck Morschhauser; Jean Nichols; Swaminathan Padmanabhan; Lauren Pinter-Brown; H Miles Prince; Barbara Pro; Andrei Shustov; Lubomir Sokol; Martin Wilhelm; Steven Horwitz
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.
Elise A Olsen; Alain H Rook; John Zic; Youn Kim; Pierluigi Porcu; Christiane Querfeld; Gary Wood; Marie-France Demierre; Mark Pittelkow; Lynn D Wilson; Lauren Pinter-Brown; Ranjana Advani; Sareeta Parker; Ellen J Kim; JACQUELINE JUNKINS-HOPKINS; Francine M Foss; Patrick Cacchio; Madeleine Duvic
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).
Madeleine Duvic; Francine M Foss
Mycosis fungoides: pathophysiology and emerging therapies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francine Foss (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Bertrand Coiffier; Francine M Foss; Matthew Greenwood; Barbara Balser; John Balser; Peter Borchmann; Dolores Caballero; Susan Carroll; Franck Morschhauser; Jean Nichols; Swaminathan Padmanabhan; Lauren Pinter-Brown; H Miles Prince; Barbara Pro; Andrei Shustov; Lubomir Sokol; Martin Wilhelm; Steven Horwitz
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(6):631-6.
2011: Elise A Olsen; Alain H Rook; John Zic; Youn Kim; Pierluigi Porcu; Christiane Querfeld; Gary Wood; Marie-France Demierre; Mark Pittelkow; Lynn D Wilson; Lauren Pinter-Brown; Ranjana Advani; Sareeta Parker; Ellen J Kim; JACQUELINE JUNKINS-HOPKINS; Francine M Foss; Patrick Cacchio; Madeleine Duvic
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).
Journal of the American Academy of Dermatology 2011;64(2):352-404.
2007: Madeleine Duvic; Francine M Foss
Mycosis fungoides: pathophysiology and emerging therapies.
Seminars in oncology 2007;34(6 Suppl 5):S21-8.
2007: Timothy M Kuzel; Shuli Li; John W Eklund; Francine M Foss; Randy D Gascoyne; Neil Abramson; John F Schwerkoske; Edie Weller; Sandra J Horning
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.
Leukemia & lymphoma 2007;48(12):2397-402.
2007: Elise A Olsen; Youn H Kim; Timothy M Kuzel; Theresa R Pacheco; Francine M Foss; Sareeta Parker; Stanley R Frankel; Cong Chen; Justin L Ricker; Jean Marie Arduino; Madeleine Duvic
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3109-15.
2006: Kevin M Chin; Francine M Foss
Biologic correlates of response and survival in patients with cutaneous T-cell lymphoma treated with denileukin diftitox.
Clinical lymphoma & myeloma 2006;7(3):199-204.
2006: Madeleine Duvic; Matthew L Sherman; Gary S Wood; Timothy M Kuzel; Elise Olsen; Francine M Foss; Robert J Laliberté; John L Ryan; Kristilyn Zonno; Alain H Rook
A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Journal of the American Academy of Dermatology 2006;55(5):807-13.
2005: Francine M Foss; Marie-France Demierre; Gina DiVenuti
A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.
Blood 2005;106(2):454-7.
2005: ZuoMing Huang; Beth Higgins; Francine M Foss
Activity of gallium nitrate in refractory peripheral T-cell lymphoma.
Clinical lymphoma 2005;6(1):43-5.
2005: Francine M Foss; Gina DiVenuti; K Chin; Kellie Sprague; Howard Grodman; A Klein; Geoffrey Chan; K Stiffler; Kenneth B Miller
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Bone marrow transplantation 2005;35(12):1187-93.
2004: Francine M Foss
Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.
Best practice & research. Clinical haematology 2004;17(4):573-84.
2004: Francine M Foss
Mycosis fungoides and the Sézary syndrome.
Current opinion in oncology 2004;16(5):421-8.
2004: Kenneth B Miller; TF Roberts; Geoffrey Chan; David P Schenkein; D Lawrence; Kellie Sprague; Gullu T Gorgun; V Relias; Howard Grodman; A Mahajan; Francine M Foss
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Bone marrow transplantation 2004;33(9):881-9.
2003: Gina Di Venuti; Rangana Nawgiri; Francine M Foss
Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphoma.
Clinical lymphoma 2003;4(3):176-8.
2003: Francine M Foss; Thomas Waldmann
Interleukin-2 receptor-directed therapies for cutaneous lymphomas.
Hematology/oncology clinics of North America 2003;17(6):1449-58.
2003: Geoffrey W Chan; Francine M Foss; Andreas K Klein; Kellie Sprague; Kenneth B Miller
Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(12):753-9.
2003: Francine M Foss
Extracorporeal photopheresis in the treatment of graft-vs-host disease.
Journal of cutaneous medicine and surgery 2003;7(4 Suppl):13-7.
2003: Geoffrey W Chan; Gullu T Gorgun; Kenneth B Miller; Francine M Foss
Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):170-6.
2003: Francine M Foss
Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.
Leukemia & lymphoma 2003;44 Suppl 3():S55-61.
2002: Richard H Shao; Xuejun Tian; Gullu T Gorgun; Alexander Urbano; Francine M Foss
Arginine butyrate increases the cytotoxicity of DAB(389)IL-2 in leukemia and lymphoma cells by upregulation of IL-2Rbeta gene.
Leukemia research 2002;26(12):1077-83.
2002: Güllü Görgün; Johanna van der Spek; Larry Cosenza; Adnan Menevse; Francine M Foss
Altered biological activity associated with C-terminal modifications of IL-7.
Cytokine 2002;20(1):17-22.
2002: Lars E French; T Alcindor; Michael Shapiro; Karen S McGinnis; D J Margolis; David Porter; Debra G B Leonard; Alain H Rook; Francine M Foss
Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.
Bone marrow transplantation 2002;30(8):509-15.
2002: Gullu T Gorgun; Francine M Foss
Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox.
Blood 2002;100(4):1399-403.
2002: Gullu T Gorgun; Kenneth B Miller; Francine M Foss
Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Blood 2002;100(3):941-7.
2002: Francine M Foss
Immunologic mechanisms of antitumor activity.
Seminars in oncology 2002;29(3 Suppl 7):5-11.
2002: Francine M Foss; Gullu T Gorgun; Kenneth B Miller
Extracorporeal photopheresis in chronic graft-versus-host disease.
Bone marrow transplantation 2002;29(9):719-25.
2002: Larry Cosenza; Gullu T Gorgun; Alexander Urbano; Francine M Foss
Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines.
Cellular signalling 2002;14(4):317-25.
2002: Johanna C vanderSpek; John A Sutherland; Brian M Gill; Gullu T Gorgun; Francine M Foss; John R Murphy
Structure function analysis of interleukin 7: requirement for an aromatic ring at position 143 of helix D.
Cytokine 2002;17(5):227-33.
2002: Jasmin Abd-el-Baki; Marie-France Demierre; Ning Li; Francine M Foss
Transformation in mycosis fungoides: the role of methotrexate.
Journal of cutaneous medicine and surgery 2002;6(2):109-16.
2002: Madeleine Duvic; Timothy M Kuzel; Elise A Olsen; Ann Martin; Francine M Foss; Youn H Kim; Peter Heald; Patricia A Bacha; Jean Nichols; Astra Liepa
Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK).
Clinical lymphoma 2002;2(4):222-8.
2002: Alexander Urbano; Gullu T Gorgun; Francine M Foss
Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cells.
Biochemical pharmacology 2002;63(4):689-92.
2001: Alain H Rook; Mohamed H Zaki; Maria Wysocka; Gary S Wood; Madeleine Duvic; Louise C Showe; Francine M Foss; Michael Shapiro; Timothy M Kuzel; Elise A Olsen; Eric Vonderheid; R Laliberte; Matthew L Sherman
The role for interleukin-12 therapy of cutaneous T cell lymphoma.
Annals of the New York Academy of Sciences 2001;941():177-84.
2001: Francine M Foss
Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma.
Annals of the New York Academy of Sciences 2001;941():166-76.
2001: T Alcindor; Gullu T Gorgun; Kenneth B Miller; TF Roberts; Kellie Sprague; David P Schenkein; Francine M Foss
Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease.
Blood 2001;98(5):1622-5.
2001: Francine M Foss; Patricia A Bacha; K E Osann; Marie-France Demierre; T Bell; Timothy M Kuzel
Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication.
Clinical lymphoma 2001;1(4):298-302.
2001: Elise Olsen; Madeleine Duvic; A Frankel; Y Kim; Ann Martin; Eric Vonderheid; B Jegasothy; G Wood; Michael S Gordon; Peter Heald; Allan R Oseroff; L Pinter-Brown; G Bowen; Timothy M Kuzel; David P Fivenson; Francine M Foss; M Glode; Arturo Molina; E Knobler; S Stewart; K Cooper; S Stevens; F Craig; J Reuben; Patricia A Bacha; J Nichols
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):376-88.
2001: Athanassios Argiris; Peter Heald; T Kuzel; Francine M Foss; Susan A DiStasio; Dennis L Cooper; S Arbuck; John R Murren
Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma.
Investigational new drugs 2001;19(4):321-6.
2000: Francine M Foss
DAB(389)IL-2 (denileukin diftitox, ONTAK): a new fusion protein technology.
Clinical lymphoma 2000;1 Suppl 1():S27-31.
2000: Francine M Foss
An oncologist's approach to therapy for cutaneous T-cell lymphoma.
Clinical lymphoma 2000;1 Suppl 1():S9-14.
2000: Francine M Foss
DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma.
Clinical lymphoma 2000;1(2):110-6; discussion 117.
2000: Francine M Foss
Combination therapy with purine nucleoside analogs.
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):31-5.
2000: Francine M Foss
Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
Seminars in oncology 2000;27(2 Suppl 5):58-63.
1999: Francine M Foss; T M Kuzel
Novel treatment approaches for cutaneous T-cell lymphoma.
Cancer treatment and research 1999;99():227-40.
1998: Alexander Urbano; R McCaffrey; Francine M Foss
Isolation and characterization of NUC70, a cytoplasmic, hematopoietic apoptotic endonuclease.
The Journal of biological chemistry 1998;273(52):34820-7.
1998: Jasmin Abd-el-Baki; Catherine M Stefanato; Howard K Koh; Marie-France Demierre; Francine M Foss
Early detection of cutaneous lymphoma.
Oncology (Williston Park, N.Y.) 1998;12(10):1521-30; discussion 1532-4.
1998: Mansoor N Saleh; Charles F LeMaistre; Timothy M Kuzel; Francine M Foss; L C Platanias; G Schwartz; M Ratain; A Rook; Cesar O Freytes; F Craig; J Reuben; M W Sams; JC Nichols
Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
Journal of the American Academy of Dermatology 1998;39(1):63-73.
1998: Alexander Urbano; Y Koc; Francine M Foss
Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells.
Leukemia 1998;12(6):930-6.
1998: E B Sweeney; Francine M Foss; John R Murphy; Johanna C vanderSpek
Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
Bioconjugate chemistry 1998;9(2):201-7.
1998: Charles F LeMaistre; Mansoor N Saleh; Timothy M Kuzel; Francine M Foss; L C Platanias; G Schwartz; M Ratain; A Rook; Cesar O Freytes; F Craig; J Reuben; JC Nichols
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2.
Blood 1998;91(2):399-405.
1998: Francine M Foss; Mansoor N Saleh; J G Krueger; JC Nichols; John R Murphy
Diphtheria toxin fusion proteins.
Current topics in microbiology and immunology 1998;234():63-81.
1997: Marie-France Demierre; Francine M Foss; Howard K Koh
Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations. Boston, Massachusetts, Oct. 1 and 2, 1994.
Journal of the American Academy of Dermatology 1997;36(3 Pt 1):460-6.
1997: J Nichols; Francine M Foss; T M Kuzel; Charles F LeMaistre; L Platanias; M J Ratain; A Rook; M Saleh; G Schwartz
Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies.
European journal of cancer (Oxford, England : 1990) 1997;33 Suppl 1():S34-6.
1996: Steven A Bogen; D Pelley; M Charif; Margaret E McCusker; H Koh; Francine M Foss; M Garifallou; C Arkin; D Zucker-Franklin
Immunophenotypic identification of Sezary cells in peripheral blood.
American journal of clinical pathology 1996;106(6):739-48.
1995: Francine M Foss; T M Kuzel
Experimental therapies in the treatment of cutaneous T-cell lymphoma.
Hematology/oncology clinics of North America 1995;9(5):1127-37.
1995: Francine M Foss; Edward A Sausville
Prognosis and staging of cutaneous T-cell lymphoma.
Hematology/oncology clinics of North America 1995;9(5):1011-9.
1995: Bruce D Cheson; Francine M Foss; P H Phillips
Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome.
Oncology (Williston Park, N.Y.) 1995;9(7):645-6.
1994: M Kuchnio; Edward A Sausville; Elaine S Jaffe; T Greiner; Francine M Foss; J McClanahan; PI Fukushima; Maryalice Stetler-Stevenson
Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression.
American journal of clinical pathology 1994;102(6):856-60.
1994: Bruce D Cheson; Don Vena; Francine M Foss; JM Sorensen
Neurotoxicity of purine analogs: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(10):2216-28.
1994: Francine M Foss; D C Ihde; I R Linnoila; A B Fischmann; G P Schechter; J D Cotelingam; Seth M Steinberg; B C Ghosh; J L Stocker; A Bastian
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(10):2051-9.
1994: R Cohen; Elaine S Jaffe; Maryalice Stetler-Stevenson; Edward A Sausville; E C DeNigris; T Woodworth; Francine M Foss
Bilateral adrenal hemorrhage and adrenal insufficiency in a patient with lymphomatous adrenal infiltration following administration of a fusion toxin (DAB486 interleukin-2).
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(3):229-33.
1994: Francine M Foss; T A Borkowski; M Gilliom; Maryalice Stetler-Stevenson; Elaine S Jaffe; William D Figg; AC Tompkins; A Bastian; P Nylen; T Woodworth
Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study.
Blood 1994;84(6):1765-74.
1994: Francine M Foss; Y Koc; Maryalice Stetler-Stevenson; D T Nguyen; M C O'Brien; R Turner; Edward A Sausville
Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):326-35.
1993: S J Graham; R W Sharpe; Seth M Steinberg; J D Cotelingam; Edward A Sausville; Francine M Foss
Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome.
Cancer 1993;72(3):726-34.
1992: Francine M Foss; D C Ihde; D L Breneman; R M Phelps; A B Fischmann; G P Schechter; I Linnoila; John C. Breneman; J D Cotelingam; B C Ghosh
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1907-13.
1989: Frederic J Kaye; P A Bunn; Seth M Steinberg; J L Stocker; D C Ihde; A B Fischmann; E J Glatstein; G P Schechter; R M Phelps; Francine M Foss
A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
The New England journal of medicine 1989;321(26):1784-90.
1989: Lyn A Mickley; Susan E Bates; N D Richert; S Currier; S Tanaka; Francine M Foss; Neal Rosen; Antonio Tito Fojo
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.
The Journal of biological chemistry 1989;264(30):18031-40.
1989: Francine M Foss; A Veillette; Oliver Sartor; Neal Rosen; J B Bolen
Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Oncogene research 1989;5(1):13-23.
1987: A Veillette; Francine M Foss; Edward A Sausville; J B Bolen; Neal Rosen
Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines.
Oncogene research 1987;1(4):357-74.